Search
Advances in omics and specifically genomic technologies are increasingly transforming rare disease diagnosis. However, the benefits of these advances are disproportionately experienced within and between populations, with Indigenous populations frequently experiencing diagnostic and therapeutic inequities. The International Rare Disease Research Consortium (IRDiRC) multi-stakeholder partnership has been advancing toward the vision of all people living with a rare disease receiving an accurate diagnosis, care, and available therapy within 1 year of coming to medical attention. In order to further progress toward this vision, IRDiRC has created a taskforce to explore the access barriers to diagnosis of rare genetic diseases faced by Indigenous peoples, with a view of developing recommendations to overcome them.
The proteins examined were the homologues of the P4, P6, P26, and D15 proteins of Haemophilus influenzae.
Human rhinoviruses (HRV) are associated with upper and lower respiratory illnesses, including severe infections causing hospitalization in both children...
Tropomyosins represent clinically relevant seafood allergens but the role of mite tropomyosin
Scabies infestations are difficult to diagnose clinically and current serologic tests have less than 50% accuracy...
This study evaluated the relationship between cat allergen–specific biomarkers in adults with cat allergy with and without cat ownership.
The aim of this study was to identify features of innate, cell-mediated and humoral immunity that may increase susceptibility to respiratory infections in...
Allergic diseases are characterized by excessive immunoglobulin E (IgE) production, mast cell degranulation, tissue eosinophilia and mucus hypersecretion
Measures of allergic sensitization and therapeutic strategies could be optimized with knowledge of Der p 2 variants
When the allergen nomenclature system was adopted in 1986, allergens were identified by their behavior on electrophoresis and chromatography...